Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies (Q45246419)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q109984365)
(P304) 2502-2512
(P407) (Q1860)
(P433) 11
(P478) 23
(P577) Monday, January 31, 2005
(P921) (Q181600)
(P1433) (Q400292)
(P1476) "Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies" (language: en)
(P2093) Neil L Spector
Wenle Xia
Howard Burris
Herbert Hurwitz
Afshin Dowlati
Bert O'Neil
Beth Overmoyer
Paul K Marcom
Kimberly L Blackwell
Deborah A Smith
Kevin M Koch
Andrew Stead
Steven Mangum
Matthew J Ellis
Leihua Liu
Albert K Man
Troy M Bremer
Jennifer Harris
Sarah Bacus
other details
description scientific article

External Links